Should vitamin K injection be continued and should tranexamic acid be continued in a patient on warfarin with bleeding whose INR has been corrected to 1.01?

Discontinue Both Vitamin K and Tranexamic Acid Now

With an INR corrected to 1.01, you should stop both vitamin K injections and tranexamic acid immediately. The bleeding has been controlled and anticoagulation has been successfully reversed—continuing these agents provides no additional benefit and may complicate restarting anticoagulation.

Rationale for Stopping Vitamin K

Why Vitamin K Is No Longer Needed

The most recent 2025 French guidelines 11 provide clear direction: vitamin K is indicated for active reversal when INR is elevated (>1.5 for severe bleeding, >1.2 for intracranial bleeding). Once INR is corrected to 1.01:

• The reversal goal has been achieved - Your patient's INR is now in the normal range (0.8-1.2)
• Vitamin K's effect persists - The drug continues working for days after administration, maintaining INR suppression 23
• Restarting anticoagulation becomes difficult - Continued vitamin K administration will make it harder to re-establish therapeutic anticoagulation when clinically appropriate 1

Monitoring After Stopping Vitamin K

The 2025 guidelines recommend checking INR at 6-8 hours and 24 hours after initial reversal 111. Since your patient's INR is already 1.01, you should:

• Monitor INR at 24 hours to ensure it remains stable
• Watch for rebound - though unlikely with warfarin given its long half-life
• Do NOT give additional vitamin K unless INR rises back above therapeutic thresholds with recurrent bleeding

Rationale for Stopping Tranexamic Acid

Limited Evidence in Anticoagulant-Associated Bleeding

The 2025 French guidelines 1111 state that tranexamic acid should be used "according to the same indications as in a patient not treated with an anticoagulant" (GRADE 1+). However, the evidence shows:

• No proven benefit in most anticoagulant-related bleeds - The HALT-IT study found tranexamic acid ineffective in upper GI bleeding regardless of anticoagulant use 1
• Ineffective in intracranial hemorrhage - TICH-NOAC showed no reduction in hematoma progression in DOAC-associated ICH 11
• Not recommended for VKA-associated ICH by the European Stroke Organisation 1

When Tranexamic Acid Has Value

Tranexamic acid is only beneficial in specific scenarios with anticoagulated patients:

• Severe trauma with hemorrhage risk
• Emergency cardiac surgery
• Post-partum hemorrhage
• Epistaxis (reduces 10-day recurrence) 1
• Dental procedures 1

Your patient does not fit these indications - the bleeding has been controlled and INR corrected.

Clinical Algorithm Moving Forward

Immediate Actions (Now)

1. Stop vitamin K injections
2. Stop tranexamic acid
3. Continue warfarin cessation until bleeding risk reassessed

Short-Term Monitoring (24-48 hours)

1. Check INR at 24 hours post-reversal 11
2. Assess bleeding control - ensure no rebleeding
3. Evaluate thrombotic risk - determine when to restart anticoagulation

Restarting Anticoagulation

Per the 2020 ACC guidelines 4, once the patient is stable and bleeding controlled, consider restarting anticoagulation based on:

• Thrombotic risk (indication for warfarin)
• Bleeding source identified and treated
• Patient stability

The 2025 French guidelines 1 emphasize that early reversal with PCC and vitamin K reduces mortality by 50% in severe bleeding, but this benefit is achieved through acute reversal, not prolonged administration.

Common Pitfalls to Avoid

• Over-treating with continued vitamin K - This is the most common error. Once INR is corrected, additional vitamin K only complicates future management
• Assuming tranexamic acid helps all bleeding - It has very specific indications and no proven benefit in most anticoagulant-related bleeds
• Delaying anticoagulation restart - Once stable, assess thrombotic risk and restart when appropriate (typically within days to weeks depending on bleeding severity) 4
• Not monitoring for INR rebound - Though rare with warfarin, check INR at 24 hours 11

Bottom line: Your reversal was successful. Stop both agents now and focus on monitoring stability and planning anticoagulation resumption.